Skip to main content

Vereckei Algorithm for Ventricular Tachycardia (VT)

Vereckei Algorithm for Ventricular Tachycardia (VT)

Vereckei Algorithm for Ventricular Tachycardia (VT)

A Detailed ECG-Based Diagnostic Guide


Wide complex tachycardia (WCT) is a common and critical ECG challenge. The most important rule in clinical cardiology is: any WCT should be considered VT until proven otherwise. The Vereckei algorithm is a simplified, stepwise ECG approach developed to differentiate VT from supraventricular tachycardia with aberrant conduction (SVT-A), using mainly lead aVR and avoiding complex morphological criteria.


This algorithm is especially useful in emergency settings, critical care, and examinations.



---


Background and Rationale


Traditional algorithms (Brugada, Wellens) rely on multiple precordial lead patterns and can be difficult to apply quickly. Vereckei et al. proposed a simpler method based on the observation that initial ventricular activation during VT is abnormal, whereas SVT conducts rapidly through the His–Purkinje system.


The algorithm answers one question at each step. If the answer is “yes,” the diagnosis is VT and the evaluation stops.



---


The Vereckei Algorithm – Stepwise Approach


Step 1: Is there an initial R wave in lead aVR?


Look specifically at lead aVR.


• Presence of a dominant initial R wave in aVR strongly favors VT

• Normal supraventricular activation produces an initial negative deflection in aVR


If YES → VT

If NO → go to Step 2


Why this works:

VT often originates away from the His–Purkinje system, producing an abnormal initial vector directed toward aVR.



---


Step 2: Is the initial r or q wave width ≥ 40 ms in aVR?


Measure the duration of the first deflection (either r or q wave) in lead aVR.


• ≥ 40 ms (1 small ECG box) → VT

• < 40 ms → go to Step 3


Rationale:

In VT, myocardial cell-to-cell conduction is slow, prolonging the initial ventricular activation.



---


Step 3: Is there a notch on the descending limb of a negative QRS in aVR?


Look for notching or slurring on the downstroke of a predominantly negative QRS complex in aVR.


• Presence of notch → VT

• Absence → go to Step 4


Rationale:

Notching reflects delayed and heterogeneous ventricular activation, typical of VT.



---


Step 4: Vi/Vt Ratio (Velocity of Initial vs Terminal Activation)


This is the most important and most specific step.


• Vi = voltage change during the first 40 ms of the QRS

• Vt = voltage change during the last 40 ms of the QRS


Calculate visually (no exact measurement required).


• If Vi/Vt ≤ 1 → VT

• If Vi/Vt > 1 → SVT with aberrancy


Interpretation:

– VT: slow initial activation (low Vi), faster terminal activation

– SVT: fast initial activation via His–Purkinje (high Vi), slower terminal spread


This step reflects the fundamental electrophysiological difference between VT and SVT.



---


Final Diagnosis


If ANY step is positive → diagnose VT

Only if ALL steps are negative → consider SVT with aberrancy



---


Sensitivity and Specificity


• Sensitivity for VT: ~90–95%

• Specificity: ~85–90%

• Particularly accurate in patients with structural heart disease


Multiple studies have validated its reliability and ease of use.



---


Clinical Pearls


• Structural heart disease + WCT = VT until proven otherwise

• AV dissociation, fusion beats, capture beats always favor VT (outside algorithm but critical)

• Algorithm is applicable even when bundle branch block pattern is unclear

• Do not delay treatment in unstable patients for ECG analysis



---


Limitations


• Less reliable in pre-excited tachycardias (antidromic AVRT)

• Requires careful inspection of lead aVR

• Not a substitute for clinical judgment



---


Comparison with Brugada Algorithm


Vereckei Algorithm

• Fewer steps

• Relies mainly on lead aVR

• Easier for emergency use


Brugada Algorithm

• Uses multiple precordial leads

• More complex morphology analysis


Both are acceptable; Vereckei is often preferred for rapid bedside decision-making.



---


Key Takeaway


The Vereckei algorithm is a practical, physiology-based method to diagnose VT in wide complex tachycardia. By focusing on lead aVR and ventricular activation velocity, it allows fast, accurate decision-making in both clinical practice and exams.



---


References


• Vereckei A et al. New algorithm using only lead aVR for differential diagnosis of wide QRS complex tachycardia. Heart Rhythm. 2008

• ACC/AHA/HRS Guidelines on Ventricular Arrhythmias

• Braunwald’s Heart Disease, 12th Edition


For more cardiology articles and ECG infographics visit:

drmusmanjaved.com






Comments

Popular posts from this blog

STEMI ECG Criteria and Universal Definition of MI

  STEMI ECG Criteria and the Universal Definition of Myocardial Infarction: A Complete Guide for Clinicians Early and accurate diagnosis of acute myocardial infarction (AMI) remains the cornerstone of reducing morbidity and mortality in patients presenting with chest pain. Among all forms of acute coronary syndromes (ACS), ST-elevation myocardial infarction (STEMI) represents the most time-sensitive emergency, requiring immediate reperfusion therapy. This article provides a clinically relevant summary of the STEMI ECG criteria and the Universal Definition of Myocardial Infarction (UDMI), based on the latest consensus guidelines from the ESC, ACC, AHA, and WHF. --- 1. Understanding STEMI: Why Accurate ECG Interpretation Matters A 12-lead ECG remains the first and most critical diagnostic test when evaluating suspected myocardial infarction. STEMI is identified when there is evidence of acute coronary artery occlusion, producing transmural ischemia and characteristic ST-segment eleva...

π˜Όπ™£π™©π™žπ™˜π™€π™–π™œπ™ͺπ™‘π™–π™©π™žπ™€π™£ π˜Όπ™›π™©π™šπ™§ π™Žπ™©π™§π™€π™ π™š

 π˜Όπ™£π™©π™žπ™˜π™€π™–π™œπ™ͺπ™‘π™–π™©π™žπ™€π™£ π˜Όπ™›π™©π™šπ™§ π™Žπ™©π™§π™€π™ π™š in  Patient with AF and acute IS/TIA European Heart Association Guideline recommends: • 1 days after TIA • 3 days after mild stroke • 6 days after moderate stroke • 12 days after severe stroke Early anticoagulation can decrease a risk of recurrent stroke and embolic events but may increase a risk of secondary hemorrhagic transformation of brain infarcts.  The 1-3-6-12-day rule is a known consensus with graded increase in delay of anticoagulation between 1 and 12 days after onset of ischemic stroke or transient ischemic attack(TIA), according to neurological severity based on European expert opinions. However, this rule might be somewhat later than currently used in a real-world practical setting.

2025 AHA/ACC Hypertension Guidelines Key points

  2025 AHA/ACC Hypertension Guidelines Explained: A Clear Summary for Clinicians and Students Hypertension remains one of the most significant contributors to cardiovascular morbidity and mortality worldwide. With continual refinement of evidence and risk-based strategies, the 2025 AHA/ACC Hypertension Guidelines bring an updated, practical approach that clinicians can use in daily practice. To make learning easier, I’ve created a clean and modern infographic summarizing all major recommendations. You can download it below and use it for study, teaching, or clinical reference. Download Infographic (PNG): 2025 Hypertension Guideline Infographic This post breaks down the key points from the guidelines and complements the infographic for a complete understanding. --- BP Categories: Understanding the Updated Thresholds The guidelines maintain the well-established classification of blood pressure: Normal: <120 / <80 Elevated: 120–129 / <80 Stage 1 Hypertension: 130–139 and/or 8...